Caris Life Sciences, Inc. (CAI) は上場企業です ヘルスケア セクターの バイオテクノロジー 業界で事業展開. 本社所在地は Irving, TX, アメリカ. 現CEOは David Dean Halbert.
CAI を有する IPO日 2025-06-18, 1,769 名の正社員, に上場 NASDAQ Global Select, 時価総額 $5.71B.
CAI International, Inc. is a transportation finance and logistics company headquartered in San Francisco, California, operating across North America, Europe, Asia, and other international markets. The company operates through two primary segments: Container Leasing, which involves leasing, re-leasing, and disposing of container equipment under various lease structures, as well as managing repair, repositioning, and storage services; and Logistics, which provides comprehensive domestic and international services including intermodal transportation, truck brokerage, port drayage, warehousing, ocean freight, air freight, and customs brokerage. As of December 31, 2019, CAI International maintained a container fleet of approximately 1.73 million cost equivalent units and offered technology-enabled transportation management solutions such as shipment optimization, load consolidation, and Web-based visibility platforms to support supply chain efficiency.